RGD Reference Report - The gene encoding nicastrin, a major gamma-secretase component, modifies risk for familial early-onset Alzheimer disease in a Dutch population-based sample. - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

The gene encoding nicastrin, a major gamma-secretase component, modifies risk for familial early-onset Alzheimer disease in a Dutch population-based sample.

Authors: Dermaut, Bart  Theuns, Jessie  Sleegers, Kristel  Hasegawa, Hiroshi  Van den Broeck, Marleen  Vennekens, Krist'l  Corsmit, Ellen  St George-Hyslop, Peter  Cruts, Marc  van Duijn, Cornelia M  Van Broeckhoven, Christine 
Citation: Dermaut B, etal., Am J Hum Genet. 2002 Jun;70(6):1568-74. Epub 2002 Apr 24.
RGD ID: 13801052
Pubmed: PMID:11992262   (View Abstract at PubMed)
PMCID: PMC379144   (View Article at PubMed Central)

Nicastrin regulates gamma-secretase cleavage of the amyloid precursor protein by forming complexes with presenilins, in which most mutations causing familial early-onset Alzheimer disease (EOAD) have been found. The gene encoding nicastrin (NCSTN) maps to 1q23, a region that has been linked and associated with late-onset Alzheimer disease (LOAD) in various genome screens. In 78 familial EOAD cases, we found 14 NCSTN single-nucleotide polymorphisms (SNPs): 10 intronic SNPs, 3 silent mutations, and 1 missense mutation (N417Y). N417Y is unlikely to be pathogenic, since it did not alter amyloid beta secretion in an in vitro assay and its frequency was similar in case and control subjects. However, SNP haplotype estimation in two population-based series of Dutch patients with EOAD (n=116) and LOAD (n=240) indicated that the frequency of one SNP haplotype (HapB) was higher in the group with familial EOAD (7%), compared with the LOAD group (3%) and control group (3%). In patients with familial EOAD without the APOE epsilon4 allele, the HapB frequency further increased, to 14%, resulting in a fourfold increased risk (odds ratio = 4.1; 95% confidence interval 1.2-13.3; P=.01). These results are compatible with an important role of gamma-secretase dysfunction in the etiology of familial EOAD.

RGD Manual Disease Annotations    Click to see Annotation Detail View
TermQualifierEvidenceWithReferenceNotesSourceOriginal Reference(s)
Alzheimer's disease no_associationIAGP 13801052DNA:missense mutation: :417N>Y (human)RGD 
Alzheimer's disease onsetIAGP 13801052DNA:SNPs and haplotype:introns:multipleRGD 
Alzheimer's disease no_associationISONCSTN (Homo sapiens)13801052; 13801052DNA:missense mutation: :417N>Y (human)RGD 
Alzheimer's disease onsetISONCSTN (Homo sapiens)13801052; 13801052DNA:SNPs and haplotype:introns:multipleRGD 

Objects Annotated

Genes (Rattus norvegicus)
Ncstn  (nicastrin)

Genes (Mus musculus)
Ncstn  (nicastrin)

Genes (Homo sapiens)
NCSTN  (nicastrin)


Additional Information